Inactive Instrument
Abpro Corporation Stock Nasdaq
Stocks
US0008501076
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 2.36M 2.1M 1.94M 1.76M 3.31M 224M 3.36M 23.38M 9.2M 117M 8.86M 8.67M 370M | P/E 2024 |
-2.41x | P/E 2025 | -3.27x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44M 2.18M 2M 1.82M 3.42M 231M 3.48M 24.17M 9.52M 121M 9.16M 8.97M 383M | EV / Sales 2024 |
497x | EV / Sales 2025 | - |
| Free-Float |
83.91% | Yield 2024 * |
-
| Yield 2025 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.36M | |
| -4.10% | -8.35% | +38.48% | +66.99% | 66.22B | |
| -0.41% | +4.99% | +7.61% | +72.82% | 55.2B | |
| +0.74% | +7.31% | +12.50% | +88.71% | 52.79B | |
| +0.61% | +6.22% | +27.28% | +50.97% | 45.53B | |
| -1.08% | +8.76% | +21.07% | +131.38% | 43.94B | |
| -3.39% | -3.01% | +250.89% | +571.04% | 41.64B | |
| -1.67% | +8.06% | +14.17% | +56.67% | 34B | |
| -8.38% | -9.01% | +25.65% | -1.82% | 25.84B | |
| +1.30% | +6.97% | +38.37% | +28.59% | 23.51B | |
| Average | -1.64% | +3.43% | +48.45% | +118.37% | 43.19B | |
| Weighted average by Cap. | -1.69% | +3.43% | +47.06% | +122.37% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 183K 163K 150K 137K 256K 17.35M 261K 1.81M 713K 9.1M 687K 672K 28.68M | - |
| Net income | -7.23M -6.45M -5.93M -5.4M -10.13M -686M -10.3M -71.61M -28.19M -360M -27.13M -26.56M -1.13B | -2.89M -2.58M -2.37M -2.16M -4.05M -274M -4.12M -28.64M -11.27M -144M -10.85M -10.62M -453M |
| Net Debt | 478K 426K 392K 357K 669K 45.32M 681K 4.73M 1.86M 23.76M 1.79M 1.76M 74.93M | 80K 71.31K 65.63K 59.7K 112K 7.58M 114K 792K 312K 3.98M 300K 294K 12.54M |
Employees
-
